We raised a mouse monoclonal antibody (5S) against the 'a' epitope of the Hepatitis B surface antigen (HBsAg) by selecting for binding of the hybridoma supernatant in conditions that usually destabilize protein-protein interactions. This antibody, which was protective in an in vitro assay, had a high affinity with a relative dissociation constant in the nanomolar range. It also displayed stable binding to antigen in conditions that usually destabilize antigen-antibody interactions, like 30% DMSO, 8 M urea, 4 M NaCl, 1M guanidium HCl and extremes of pH. The variable regions of the antibody were cloned and expressed as an single chain variable fragment (scFv) (A5). A5 had a relative affinity comparable to the mouse monoclonal and showed antig...
The nucleotide (nt) sequences encoding the variable regions of the heavy and light chains of a murin...
The nucleotide (nt) sequences encoding the variable regions of the heavy and light chains of a murin...
<div><p>We describe the production and characterization of human monoclonal antibodies (mAb) specifi...
We raised a mouse monoclonal antibody (5S) against the 'a' epitope of the Hepatitis B surface antige...
Background: Antibody against hepatitis B surface antigen (HBsAg) is used for passive immunotherapy i...
Background: Antibody against hepatitis B surface antigen (HBsAg) is used for passive immunotherapy i...
Antibody against HBsAg (hepatitis B surface antigen) is advocated for the passive immunotherapy in c...
Hepatitis B virus (HBV) infection is a global burden on the health-care system and is considered as ...
Hepatitis B virus (HBV) infection is a global burden on the health-care system and is considered as ...
Background: Hepatitis B virus (HBV) surface antigen (HBsAg) induces a vigorous neutralizing antibody...
CDR3 of the heavy-chain variable region of immunoglobulin is a region in which somatic mutation occu...
AIM: To investigate the reactivity of a panel of 8 mouse anti-hepatitis B surface antigen (HBsAg)...
We had earlier reported the construction and characterization of a high affinity recombinant scFv ge...
BACKGROUND AND AIM: Antibodies against the "a" determinant of hepatitis B surface antigen ...
AIM: Passive immunotherapy using antibody against hepatitis B surface antigen (HBsAg) has been advoc...
The nucleotide (nt) sequences encoding the variable regions of the heavy and light chains of a murin...
The nucleotide (nt) sequences encoding the variable regions of the heavy and light chains of a murin...
<div><p>We describe the production and characterization of human monoclonal antibodies (mAb) specifi...
We raised a mouse monoclonal antibody (5S) against the 'a' epitope of the Hepatitis B surface antige...
Background: Antibody against hepatitis B surface antigen (HBsAg) is used for passive immunotherapy i...
Background: Antibody against hepatitis B surface antigen (HBsAg) is used for passive immunotherapy i...
Antibody against HBsAg (hepatitis B surface antigen) is advocated for the passive immunotherapy in c...
Hepatitis B virus (HBV) infection is a global burden on the health-care system and is considered as ...
Hepatitis B virus (HBV) infection is a global burden on the health-care system and is considered as ...
Background: Hepatitis B virus (HBV) surface antigen (HBsAg) induces a vigorous neutralizing antibody...
CDR3 of the heavy-chain variable region of immunoglobulin is a region in which somatic mutation occu...
AIM: To investigate the reactivity of a panel of 8 mouse anti-hepatitis B surface antigen (HBsAg)...
We had earlier reported the construction and characterization of a high affinity recombinant scFv ge...
BACKGROUND AND AIM: Antibodies against the "a" determinant of hepatitis B surface antigen ...
AIM: Passive immunotherapy using antibody against hepatitis B surface antigen (HBsAg) has been advoc...
The nucleotide (nt) sequences encoding the variable regions of the heavy and light chains of a murin...
The nucleotide (nt) sequences encoding the variable regions of the heavy and light chains of a murin...
<div><p>We describe the production and characterization of human monoclonal antibodies (mAb) specifi...